- Home
- FTCI vs ASRT Comparison
FTCI vs ASRT Comparison
Compare FTCI & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTCI
- ASRT
- Stock Information
- Founded
- FTCI 2017
- ASRT 1995
- Country
- FTCI United States
- ASRT United States
- Employees
- FTCI N/A
- ASRT N/A
- Industry
- FTCI Semiconductors
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- FTCI Technology
- ASRT Health Care
- Exchange
- FTCI Nasdaq
- ASRT Nasdaq
- Market Cap
- FTCI 93.0M
- ASRT 79.1M
- IPO Year
- FTCI 2021
- ASRT 1997
- Fundamental
- Price
- FTCI $6.28
- ASRT $0.80
- Analyst Decision
- FTCI Buy
- ASRT Strong Buy
- Analyst Count
- FTCI 3
- ASRT 1
- Target Price
- FTCI $4.67
- ASRT $3.00
- AVG Volume (30 Days)
- FTCI 80.1K
- ASRT 265.0K
- Earning Date
- FTCI 08-05-2025
- ASRT 08-11-2025
- Dividend Yield
- FTCI N/A
- ASRT N/A
- EPS Growth
- FTCI N/A
- ASRT N/A
- EPS
- FTCI N/A
- ASRT N/A
- Revenue
- FTCI $64,134,000.00
- ASRT $117,099,000.00
- Revenue This Year
- FTCI $90.77
- ASRT N/A
- Revenue Next Year
- FTCI $130.32
- ASRT $5.84
- P/E Ratio
- FTCI N/A
- ASRT N/A
- Revenue Growth
- FTCI N/A
- ASRT N/A
- 52 Week Low
- FTCI $2.02
- ASRT $0.51
- 52 Week High
- FTCI $7.40
- ASRT $1.38
- Technical
- Relative Strength Index (RSI)
- FTCI 55.82
- ASRT 54.77
- Support Level
- FTCI $5.87
- ASRT $0.78
- Resistance Level
- FTCI $6.48
- ASRT $0.87
- Average True Range (ATR)
- FTCI 0.54
- ASRT 0.03
- MACD
- FTCI -0.02
- ASRT -0.00
- Stochastic Oscillator
- FTCI 58.40
- ASRT 34.36
About FTCI FTC Solar Inc.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.